Company News
- CTD Announces Appointment of Sharon H. Hrynkow, PhD as Chief Scientific Officer
Feb 15, 2019, 10:04 AM EST - CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Patients with Niemann-Pick Disease Type C
Feb 7, 2019, 8:00 AM EST - CTD Announces Partnership with United BioSource LLC (UBC) to support the Extension Protocol for its Phase I Clinical Trial in the United States
Jan 18, 2019, 8:00 AM EST - CTD Announces Presentation at Upcoming Conference on Lysosomal Storage Diseases
Jan 10, 2019, 8:00 AM EST - CTD Holdings’ Senior VP for Medical Affairs Appointed to Committee of the National Academies of Sciences, Engineering, and Medicine
Jan 8, 2019, 8:52 AM EST - CTD Holdings Closes $2.0 Million Private Placement
Dec 21, 2018, 8:00 AM EST - CTD Holdings to Present at WORLD Symposium on Lysosomal Storage Diseases
Dec 12, 2018, 8:00 AM EST - CTD Holdings to Present at Brains for Brain Conference on Lysosomal Storage Diseases
Dec 10, 2018, 9:11 AM EST - CTD Holdings Engages Torreya Capital as Strategic Advisor
Nov 13, 2018, 8:43 AM EST - CTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
Nov 8, 2018, 3:07 PM EST
